In a large target trial emulation of 174,678 people with type 1 diabetes, GLP-1 receptor agonist initiation was associated ...

A recent research revealed that discontinuing GLP-1 drugs for diabetes may increase the risk of cardiac events, stroke, and ...

People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

Research finds that even short gaps in treatment with a GLP-1 can drive up risks of heart attack, stroke and death in ...

Adults with diabetes, especially younger ones, face significantly higher SCD rates, impacting life expectancy and necessitating better risk stratification and prevention strategies. SCD risk is 3.7 ...

Taking GLP-1 drugs for diabetes has been shown to lower the risk of ​adverse heart events, but a new analysis found that ...

A recent study found that stopping GLP-1s, such as Ozempic or Wegovy, can reverse the cardiovascular benefits they provide.

A University of Arkansas for Medical Sciences assistant professor has received a $3.6 million grant from the National ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? You already know that living with type 2 diabetes means having blood sugar ...

Data are lacking about the relationship between type 2 diabetes and the risks of heart failure (HF) among people with elevated cardiac biomarkers. This information is particularly scant among Black ...

One in 3 adults reports not getting the approximately seven hours of recommended sleep per night. That may be sustainable for ...